,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-09-11 07:06:00,"Chicago, IL - September 11, 2017 - Zacks.com announces the list of stocks featured in the Analyst Blog.",0.01729399710893631,0.009129728190600872,0.9735763072967529,neutral,0.008164268918335438
1,2017-09-11 07:06:00,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2017-09-11 07:06:00,"Stocks recently featured in the blog include Home Depot (NYSE: HD- Free Report ), Aetna (NYSE: AET- Free Report ), Dickinson (NYSE: BDX- Free Report ), Kellogg (NYSE: K- Free Report ) and FirstEnergy (NYSE: FE- Free Report ).",0.02096949890255928,0.009834776632487774,0.9691957235336304,neutral,0.011134722270071507
3,2017-09-11 07:06:00,"Today, Zacks is promoting its ''Buy'' stock recommendations.",0.3684377670288086,0.010614300146698952,0.6209479570388794,neutral,0.3578234612941742
4,2017-09-11 07:06:00,Get #1Stock of the Day pick for free.,0.0864095613360405,0.03249066323041916,0.8810997605323792,neutral,0.05391889810562134
5,2017-09-11 07:06:00,"Here are highlights from Friday's Analyst Blog:

The Zacks Research Daily presents the best research output of our analyst team.",0.2284756302833557,0.009567669592797756,0.7619567513465881,neutral,0.21890796720981598
6,2017-09-11 07:06:00,"Today's Research Daily features new research reports on 16 major stocks, including Home Depot (NYSE: HD- Free Report ), Aetna (NYSE: AET- Free Report ) and Becton, Dickinson (NYSE: BDX- Free Report ).",0.03885006532073021,0.007404609117656946,0.9537453651428223,neutral,0.0314454548060894
7,2017-09-11 07:06:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
8,2017-09-11 07:06:00,"You can see all of today's research reports here >>>

Home Depot 's shares are up +26.7% over the last year, outperforming the Zacks Retail sector (up +17.8%) as well as the broader market (S&P 500 up +18.3%) in that same time period.",0.9314317107200623,0.036909837275743484,0.031658466905355453,positive,0.8945218920707703
9,2017-09-11 07:06:00,"The company has been consistently gaining from its interconnected strategy, focus on Pro customers, and housing market recovery.",0.9466332793235779,0.015345362015068531,0.03802133724093437,positive,0.931287944316864
10,2017-09-11 07:06:00,"These factors helped the company post a stellar second-quarter fiscal 2017 performance, which marked its highest ever quarterly sales and earnings.",0.9512888789176941,0.02040966786444187,0.02830136939883232,positive,0.9308792352676392
11,2017-09-11 07:06:00,"Pro category sales continued to outperform, driven by constant efforts to enrich customers' experiences.",0.8348273038864136,0.1267891377210617,0.038383591920137405,positive,0.7080381512641907
12,2017-09-11 07:06:00,The sturdy first half performance and expectations of improved home prices encouraged the company to raise its fiscal 2017 view.,0.8334731459617615,0.019714873284101486,0.14681199193000793,positive,0.8137582540512085
13,2017-09-11 07:06:00,"However, gross margin remains plateaued, and is likely to fall 10 bps in fiscal 2017.",0.01657288521528244,0.9660304188728333,0.017396721988916397,negative,-0.9494575262069702
14,2017-09-11 07:06:00,"Also, competition from online retailers may impact results.",0.0182954054325819,0.8997437357902527,0.08196083456277847,negative,-0.8814483284950256
15,2017-09-11 07:06:00,(You can read the full research report on Home Depot here >>> ) .,0.012610534206032753,0.013505421578884125,0.973884105682373,neutral,-0.0008948873728513718
16,2017-09-11 07:06:00,Shares of Buy-rated Aetna have outperformed the Zacks Health Maintenance Organization industry year to date (up +31.4% vs. +28.3%).,0.8043768405914307,0.17246994376182556,0.023153234273195267,positive,0.6319068670272827
17,2017-09-11 07:06:00,The Zacks analyst expects the company to derive long-term growth from its Government business.,0.8501964807510376,0.01059853844344616,0.13920506834983826,positive,0.8395979404449463
18,2017-09-11 07:06:00,Cost-reduction initiatives and growing ACO collaborations have paved the way for long-term growth.,0.9310519695281982,0.014949836768209934,0.053998224437236786,positive,0.9161021113395691
19,2017-09-11 07:06:00,A strong balance sheet is another positive.,0.7850011587142944,0.01486221794039011,0.20013664662837982,positive,0.7701389193534851
20,2017-09-11 07:06:00,Its International expansion is also perceived as an opportunity in the face of increased regulation in the U.S.,0.9209170937538147,0.01484457403421402,0.06423830986022949,positive,0.9060724973678589
21,2017-09-11 07:06:00,"Following strong second-quarter results, Aetna raised its earnings guidance which cements investors' confidence in the company.",0.9541099071502686,0.01875007338821888,0.027140002697706223,positive,0.9353598356246948
22,2017-09-11 07:06:00,(You can read the full research report on Aetna here >>> ) .,0.013153256848454475,0.011723117902874947,0.9751235842704773,neutral,0.0014301389455795288
23,2017-09-11 07:06:00,"Becton, Dickinson 's shares have outperformed the Zacks Dental Supplies industry year to date, gaining +22.3% vs. +18%.",0.5521098971366882,0.4278489053249359,0.020041197538375854,positive,0.12426099181175232
24,2017-09-11 07:06:00,"The company is steadily progressing with its planned acquisition of medical technology player, C. R. Bard.",0.8643395304679871,0.01187538355588913,0.12378513813018799,positive,0.8524641394615173
25,2017-09-11 07:06:00,The $24-billion transaction is slated to be completed in the fourth quarter of fiscal 2017.,0.07080870866775513,0.004395976662635803,0.9247952699661255,neutral,0.06641273200511932
26,2017-09-11 07:06:00,"Post completion, BD expects growth in adjusted earnings starting fiscal 2019.",0.9501224160194397,0.015336413867771626,0.03454115614295006,positive,0.9347860217094421
27,2017-09-11 07:06:00,The Zacks analyst thinks the acquisition as a strategic fit which will generate benefits from complementary businesses and geographical expansion.,0.9261611104011536,0.012903636321425438,0.06093524396419525,positive,0.9132574796676636
28,2017-09-11 07:06:00,BD's cost-control initiatives are also noteworthy.,0.8178971409797668,0.012777204625308514,0.16932564973831177,positive,0.8051199316978455
29,2017-09-11 07:06:00,"On the flipside, unfavorable sales performance from the BD Medical segment is a concern in the near term.",0.02344381995499134,0.9517518877983093,0.02480422332882881,negative,-0.9283080697059631
30,2017-09-11 07:06:00,"Performance in the segment was affected by sluggishness in the Medication Management Solutions and Pharmaceutical Systems units in the U.S. (You can read the full research report on Becton, Dickinson here >>> ) .",0.018586698919534683,0.9460886716842651,0.03532463684678078,negative,-0.9275019764900208
31,2017-09-11 07:06:00,Other noteworthy reports we are featuring today include Kellogg (NYSE: K- Free Report ) and FirstEnergy (NYSE: FE- Free Report ).,0.031115233898162842,0.0062174624763429165,0.9626673460006714,neutral,0.024897770956158638
32,2017-09-11 07:06:00,More Stock News: This Is Bigger than the iPhone!,0.3262152671813965,0.02558426558971405,0.648200511932373,neutral,0.30063098669052124
33,2017-09-11 07:06:00,It could become the mother of all technological revolutions.,0.3357715904712677,0.018597140908241272,0.6456312537193298,neutral,0.31717443466186523
34,2017-09-11 07:06:00,"Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.",0.5349074602127075,0.016818122938275337,0.4482743740081787,positive,0.5180893540382385
35,2017-09-11 07:06:00,Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it.,0.21044442057609558,0.009386956691741943,0.7801685333251953,neutral,0.20105746388435364
36,2017-09-11 07:06:00,"If you don't buy now, you may kick yourself in 2020.",0.08301617205142975,0.28448015451431274,0.6325036883354187,neutral,-0.201463982462883
37,2017-09-11 07:06:00,"Click here for the 6 trades >>

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar.",0.06148247793316841,0.5701280236244202,0.3683894872665405,negative,-0.5086455345153809
38,2017-09-11 07:06:00,They're virtually unknown to the general public.,0.035764459520578384,0.0785161554813385,0.885719358921051,neutral,-0.04275169596076012
39,2017-09-11 07:06:00,"Yet today's 220 Zacks Rank #1 ""Strong Buys"" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015.",0.6580293774604797,0.017276067286729813,0.32469451427459717,positive,0.6407533288002014
40,2017-09-11 07:06:00,Its average gain has been a stellar +26% per year.,0.8422174453735352,0.0191669799387455,0.13861553370952606,positive,0.8230504393577576
41,2017-09-11 07:06:00,See these high-potential stocks free >>.,0.12527841329574585,0.05778927728533745,0.8169323205947876,neutral,0.0674891322851181
42,2017-09-11 07:06:00,"Get the full Report on HD - FREE

Get the full Report on AET - FREE

Get the full Report on BDX - FREE

Get the full Report on K - FREE

Get the full Report on FE - FREE

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.",0.013268372975289822,0.009014081209897995,0.9777175188064575,neutral,0.004254291765391827
43,2017-09-11 07:06:00,Past performance is no guarantee of future results.,0.023727279156446457,0.008731111884117126,0.9675416350364685,neutral,0.01499616727232933
44,2017-09-11 07:06:00,Inherent in any investment is the potential for loss.,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
45,2017-09-11 07:06:00,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
46,2017-09-11 07:06:00,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
47,2017-09-11 07:06:00,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
48,2017-09-11 07:06:00,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
49,2017-09-11 07:06:00,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
50,2017-09-11 07:06:00,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
51,2017-09-11 07:06:00,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
52,2017-09-11 07:06:00,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
53,2017-09-11 07:06:00,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
54,2017-09-11 07:06:00,Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01078665629029274,0.015373211354017258,0.9738401174545288,neutral,-0.004586555063724518
55,2017-09-11 07:06:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
56,2017-09-11 07:06:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
57,2017-09-11 07:06:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
58,2017-09-11 07:06:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
